Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,562.10 +181.12 1.18%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,170.20 -9.86 -0.19%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Therapeutics

Immtech Pharmaceuticals Inc

+ Add to Watchlist

IMMP:US

0.0080 USD 0.00000.00%

As of 20:10:00 ET on 05/21/2013.

Company Profile for Immtech Pharmaceuticals Inc (IMMP)

Immtech Pharmaceuticals Inc. is a pharmaceutical company advancing the development and commercialization of oral drugs to treat infectious diseases. The Company is also extending the use of its proprietary library of compounds to treat cancer, diabetes, and other diseases. Immtech has programs for malaria, fungal infections, tuberculosis, and other diseases.

Contact Information

Immtech Pharmaceuticals Inc

One North End Avenue
New York, NY 10282
United States
Phone: 1-212-791-2911
Fax: 1-212-791-2917

Key Executives for Immtech Pharmaceuticals Inc (IMMP)

Eric L SorkinChairman/President/CEOCecilia ChanVice Chairman
Gary C ParksCFO/Treasurer/SecretaryNorman A AboodSenior VP:Discovery Programs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil